EXEVYCO
LIVE
Serial Number
79319484
Owner
ExeVir Bio, Besloten VennootschapAttorney
Lindy M. HermanFiling Date
Jun 29, 2021
EXEVYCO Trademark
Serial Number: 79319484 • Registration: 6823233
EXEVYCO is a trademark filed by
ExeVir Bio, Besloten Vennootschap
on June 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Lindy M. Herman Rutan & Tucker, LLP
18575 Jamboree Road
9th Floor
Irvine
CA 92612
Trademark Details
Filing Date
June 29, 2021
Registration Date
August 23, 2022
Published for Opposition
June 7, 2022
Filing History
NEW REPRESENTATIVE AT IB RECEIVED
Feb 18, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 5, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 5, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Apr 29, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 1, 2022 ERRR
ASSIGNED TO LIE
Mar 27, 2022 ALIE
REFUSAL PROCESSED BY IB
Mar 27, 2022 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2022 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 4, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 4, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 5, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 4, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 14, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 2, 2021 REPR